Markers of inflammation are associated with clinical outcomes in patients with metastatic renal cell carcinoma treated with nivolumab

ABSTRACT:

SUBMITTER: Sznol M 

PROVIDER: S-EPMC4649555 | biostudies-literature | 2015 Jan

REPOSITORIES: biostudies-literature